LONGTERM TREATMENT EFFECTS OF INOTERSEN ON QUALITY OF LIFE IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY

被引：0
|
作者：
Brown, Duncan
Karam, Chafic
Yang, Min
Done, Nicolae
Zhu, JingJing
Greatsinger, Ali
Bozas, Ana
Llonch, Montserrat Vera
Signorovitch, James
机构：
来源：
MUSCLE & NERVE | 2021年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
105
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis
    Gertz, Morie A.
    Scheinberg, Morton
    Waddington-Cruz, Marcia
    Heitner, Stephen B.
    Karam, Chafic
    Drachman, Brian
    Khella, Sami
    Whelan, Carol
    Obici, Laura
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 701 - 711
  • [2] Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Gorevic, Peter
    Franklin, Jaclyn
    Chen, Jihong
    Sajeev, Gautam
    Wang, Jessie C. H.
    Lin, Hollis
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (01) : 121 - 129
  • [3] COST OF INOTERSEN AND PATISIRAN FOR THE TREATMENT OF ADULTS WITH POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IN CANADA, GERMANY, AND ITALY
    Brown, D.
    Vera-Llonch, M.
    Shaff, M.
    Rolli, A.
    Vega, M.
    Blum, M.
    Nestler-Parr, S.
    Jiresch, M.
    Weycker, D.
    VALUE IN HEALTH, 2020, 23 : S606 - S607
  • [4] Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
    Obici, Laura
    Ajroud-Driss, Senda
    Lin, Kon-Ping
    Berk, John L.
    Gillmore, Julian D.
    Kale, Parag
    Koike, Haruki
    Danese, David
    Aldinc, Emre
    Chen, Chongshu
    Vest, John
    Adams, David
    NEUROLOGY AND THERAPY, 2023, 12 (05) : 1759 - 1775
  • [5] Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
    Laura Obici
    Senda Ajroud-Driss
    Kon-Ping Lin
    John L. Berk
    Julian D. Gillmore
    Parag Kale
    Haruki Koike
    David Danese
    Emre Aldinc
    Chongshu Chen
    John Vest
    David Adams
    Neurology and Therapy, 2023, 12 (5) : 1759 - 1775
  • [6] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Nie, Tina
    Heo, Young-A
    Shirley, Matt
    DRUGS, 2023, 83 (15) : 1425 - 1432
  • [7] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Tina Nie
    Young-A Heo
    Matt Shirley
    Drugs, 2023, 83 : 1425 - 1432
  • [8] Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
    Conceicao, Isabel
    Berk, John L.
    Weiler, Markus
    Kowacs, Pedro A.
    Dasgupta, Noel R.
    Khella, Sami
    Chao, Chi-Chao
    Attarian, Shahram
    Kwoh, T. Jesse
    Jung, Shiangtung W.
    Chen, Jersey
    Viney, Nicholas J.
    Yu, Rosie Z.
    Gertz, Morie
    Masri, Ahmad
    Cruz, Marcia Waddington
    Coelho, Teresa
    JOURNAL OF NEUROLOGY, 2024, 271 (10) : 6655 - 6666
  • [9] Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation
    Schmidt, Hartmut H.
    Wixner, Jonas
    Plante-Bordeneuve, Violaine
    Munoz-Beamud, Francisco
    Llado, Laura
    Gillmore, Julian D.
    Mazzeo, Anna
    Li, Xingyu
    Arum, Seth
    Jay, Patrick Y.
    Adams, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (06) : 1646 - 1657
  • [10] Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
    Benson, M. D.
    Waddington-Cruz, M.
    Berk, J. L.
    Polydefkis, M.
    Dyck, P. J.
    Wang, A. K.
    Plante-Bordeneuve, V.
    Barroso, F. A.
    Merlini, G.
    Obici, L.
    Scheinberg, M.
    Brannagan, T. H., III
    Litchy, W. J.
    Whelan, C.
    Drachman, B. M.
    Adams, D.
    Heitner, S. B.
    Conceicao, I.
    Schmidt, H. H.
    Vita, G.
    Campistol, J. M.
    Gamez, J.
    Gorevic, P. D.
    Gane, E.
    Shah, A. M.
    Solomon, S. D.
    Monia, B. P.
    Hughes, S. G.
    Kwoh, T. J.
    McEvoy, B. W.
    Jung, S. W.
    Baker, B. F.
    Ackermann, E. J.
    Gertz, M. A.
    Coelho, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01): : 22 - 31
12345